Response Genetics, Inc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGDXQ research report →
About the company
Response Genetics, Inc. , a life sciences company founded in Los Angeles, California, in 1999 (originally Bio Type, Inc. , before its rebranding in August 2000), focuses on creating, advancing, and commercializing pharmacogenomic tests.
- CEO
- Thomas Bologna
- IPO
- 2007
- Employees
- 96
- HQ
- Los Angeles, CA, US
Price Chart
- Market Cap
- $3.87K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.67
- Div Yield
- 0.00%
- Gross Margin
- 21.85%
- Op Margin
- -118.50%
- Net Margin
- -111.88%
- ROE
- -126.76%
- ROIC
- -49.89%
- Revenue
- $18.04M · 7.89%
- Net Income
- $-20,184,000 · -49.11%
- EPS
- $-0.52 · -48.57%
- Op Income
- $-21,377,000
- FCF YoY
- -2.36%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.46
- Avg Volume
- 49.59K
Get TickerSpark's AI analysis on RGDXQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RGDXQ coverage
Recent articles, reports, and earnings notes.
No research on RGDXQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RGDXQ report →Similar companies
Peers in the same neighborhood.